Dr. Novack selected to be fellow of AOPT

Dr. Novack was selected to be a fellow of the Association for Ocular Pharmacology and Therapeutics.

The Association for Ocular Pharmacology and Therapeutics is a global organization for scientists and individuals from all disciplines related to ocular pharmacology and its therapeutic applications.  Fellows of AOPT are nominated by their peers based upon service to the Association and its publication,  “Journal of Ocular Pharmacology and Therapeutics”.

About Dr. Novack

Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.

He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.

Contact Dr. Novack
Contact Dr. Novack